The “Best” Diet Pill For Women Is Approved By FDA
If you’re looking for the “best” diet pill for women who are obese (according to Dr.Richard Lipman’s book), you will find this news very encouraging.
Now marks the entrance of the first new diet drug in 13 long years, with the approval to start selling Lorcaserin by the Food and Drug Administration. (To not be mistaken with Qnexa, another new diet drug, as more studies are submitted which is still awaiting FDA acceptance.) The last time the FDA gave the stamp of acceptance to a weight loss drug that is new, it was orlistat (brand name Xenical) in 1999.
Once this diet pill completely vetted by the Drug Enforcement Administration, lorcaserin will be marketed under the commercial name Belviq in the USA.
The Numbers Don’t Lie About Lorcaserin Diet Pills
In one Phase III clinical trial for Lorcaserin, known as Blossom, 7.5% of patients lost at least 5% of their body weight, compared to 20.3% for placebo. Also, 22.6% of lorcaserin patients lost at least 10% of their body weight, compared to 7.7% for placebo.
Lorcaserin patients attained a typical weight loss of 5.8% of their body weight, or 12.7 pounds, compared to 2.2%, or 4.7 pounds, for placebo.
Who Needs Lorcaserin/Belviq?
Well, the marketplace for Belviq is easily one out of every three obese men and women in America, according to the FDA’s computations. The bureau approved the drug for those obese, meaning their body mass index (BMI) is over 30, or for anyone with a BMI of 27 who also have another risk factor like high cholesterol, high blood pressure, or diabetes.
Since one out of every three Americans is obese, and another third that aren’t obese are still overweight (and likely to have at least one of the other risk factors that go with the excess weight), that may qualify close to two thirds of Americans for the new best diet pill for women. That’s major news for ARNA, a division of Arena Pharmaceuticals, maker of lorcaserin. And additionally for Vivus, manufacturer of Qnexa, which probably will get a lump in assurance from the action of the FDA.
Health Dangers: A Game of Risk vs. Advantage?
Lorcaserin’s benefits for those who are overweight or obese are quite clear, since it seems to be quite effective. There’s some question about whether lorcaserin carries at least some heart disease risk, similar to that likely to be caused by Qnexa, another new diet drug expected to acquire FDA approval within months. Qnexa was sent back for added studies due to concerns about heart valve damage, a life-threatening and permanent side effect.
After news hit that the FDA was giving Lorcaserin a thumbs up, the consumer watchdog group Public Citizen started a campaign to raise concerns about valve damage.
It is not that easy to argue against a drug that can eliminate obesity though, when you consider all the ailments and conditions, from diabetes to heart and lung disease, that come along with being seriously heavy since obesity is also VERY life-threatening.
When I wrote about the side effects of this drug, I got a bunch of negative feedback from obesity groups, who herald the arrival of any new weight loss drug as life-saving news for people who believe they don’t have any other way to shed weight.
Nevertheless, even though lorcaserin is said to be the best diet pill for men & women who are majorly overweight, I continue to believe in the research — including convincing longterm evaluation by the National Weight Control Registry — that says cautious adherence to your low-calorie diet and exercise plan that is consistent is the most effective, and safest, most wholesome way to lose weight and keep it off. That’s one of the reasons I promote intermittent fasting.